BC-1382

• Description:

  BC-1382 is a potent ubiquitin E3 ligase HECTD2 inhibitor that specificly disrupts the HECTD2/PIAS1 interaction (IC50 of 5 nM) .BC-1382, that targeted HECTD2 and attenuated lipopolysaccharide (LPS) - and Pseudomonas aeruginosa-induced lung inflammation.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  459.56

• Molecular Formula:

  C23H29N3O5S

• Notes:

  Research use only, not for human use.

• Receptor:

  Ubiquitin E3 ligase HECTD2

• CAS Number:

  1013753-99-5